Key facts
| Recalling firm | Medtronic, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Azure Astra application, Software Model Number D00U003; 2. Percepta Serena Solara application, Software Model Number D00U004; 3. Cobalt Crome application, Software Model Number D00U005; 4. Micra VR application, Software Model Number D00U006; 5. Micra AV application, Software Model Number D00U007; 6. Viva Consulta Syncra Advisa Ensura application, Software Model Number D00U008; 7. Claria Amplia Compia application, Software Model Number D00U009; 8. Evera MRI application, Software Model Number D00U010; 9. Visia AF application, Software Model Number D00U011; 10. Viva Brava Evera application, Software Model Number D00U012; 11. Micra VR2 AV2 application, Software Model Number D00U022. |
| Classification | Class II |
| Recall number | Z-2127-2025 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no reset has actually occurred and there are no parameter changes or loss of diagnostics. Prior to this software update, if an erroneous SmartSync message was displayed, confusion regarding the message could have caused a clinician to consider an unnecessary system revision. Medtronic has received 39 reports of this display error with two instances of unnecessary device explant through 30 April 2025. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Azure Astra application, Software Model Number D00U003; 2. Percepta Serena Solara application, Software Model Number D00U004; 3. Cobalt Crome application, Software Model Number D00U005; 4. Micra VR application, Software Model Number D00U006; 5. Micra AV application, Software Model Number D00U007; 6. Viva Consulta Syncra Advisa Ensura application, Software Model Number D00U008; 7. Claria Amplia Compia application, Software Model Number D00U009; 8. Evera MRI application, Software Model Number D00U010; 9. Visia AF application, Software Model Number D00U011; 10. Viva Brava Evera application, Software Model Number D00U012; 11. Micra VR2 AV2 application, Software Model Number D00U022. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Medtronic, Inc.’s FDA history
Argus HQ has recorded 40 total FDA actions tied to Medtronic, Inc.: 0 warning letters, 40 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Medtronic SmartLink Software loaded on SmartSync Patient Con recalled?
- Yes. FDA lists a Class II recall by Medtronic, Inc. for Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Azure Astra application, Software Model Number D00U003; 2. Percepta Serena Solara application, Software Model Number D00U004; 3. Cobalt Crome application, Software Model Number D00U005; 4. Micra VR application, Software Model Number D00U006; 5. Micra AV application, Software Model Number D00U007; 6. Viva Consulta Syncra Advisa Ensura application, Software Model Number D00U008; 7. Claria Amplia Compia application, Software Model Number D00U009; 8. Evera MRI application, Software Model Number D00U010; 9. Visia AF application, Software Model Number D00U011; 10. Viva Brava Evera application, Software Model Number D00U012; 11. Micra VR2 AV2 application, Software Model Number D00U022., reported 20250723, with status "Ongoing." FDA recall number: Z-2127-2025.
- What is the recall class for Medtronic, Inc.'s recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic, Inc.- Recall: Medtronic Inc — Class II recall: Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G1210009… →
- Recall: Medtronic, Inc. — Class II recall: Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable car… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic CareLink SmartSync Device Manager, Model Number 24967A with the follow… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the foll… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic SmartLink software loaded on CareLink SmartSync Device Manager, Model… →
- Recall: Medtronic, Inc. — Class II recall: Azure S DR MRI SureScan, Product number W3DR01 →
- Recall: Medtronic Inc. — Class II recall: 2090 Programmers with serial number prefixes PKK0 and PKK1: a) 2090, Product… →
- Recall: Medtronic Inc. — Class II recall: COBALT XT HF QUAD CRT-D MRI SureScan, Model Number DTPA2QQ, Implantable Cardiove… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). Recall Record: Class II Recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector,… by Medtronic, Inc.. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/medtronic-z-2127-2025-2025-07-23
"Recall Record: Class II Recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector,… by Medtronic, Inc.." Argus HQ Research, Digital Empire Holdings LLC, 2025, argushq.ai/recall/medtronic-z-2127-2025-2025-07-23.
Argus HQ Research. "Recall Record: Class II Recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector,… by Medtronic, Inc.." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/recall/medtronic-z-2127-2025-2025-07-23.
@misc{argushq_argushq_ai_recall_medtronic_z_2127_2025_2025_07_23_2025,
title = {Recall Record: Class II Recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector,… by Medtronic, Inc.},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/medtronic-z-2127-2025-2025-07-23},
note = {Accessed: August 29, 2026}
}Source: FDA.gov — Recalls ↗

